paclitaxel,CTX-009
Compass Therapeutics
[]
$cmpx compass therapeutics announces that the phase 2 data of ctx-009 in combination with paclitaxel in patients with biliary tract cancers (btc) will be presented at the asco gi cancers symposium on january 20, 2023 #cancer
Free Stock Market News are delayed 15 sec. Full features and live news available here: https://t.co/fWRacb3Vft